An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes
NCT02224573
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
681
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Dravet Syndrome
Lennox-Gastaut Syndrome
Interventions
DRUG:
GWP42003-P
Sponsor
GW Research Ltd